P08.44 Phase II study of hypofractionated radiation therapy with concomitant and adjuvant temozolomide following surgical resection for patients with newly diagnosed glioblastoma: preliminary evaluation

相似書籍

• P08.28 Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation
  由: Pessina, F., et al.
  出版: (2016)
• P08.27 The role of supramarginal resection for single large brain metastases: feasibility, morbidity and local control evaluation
  由: Pessina, F., et al.
  出版: (2016)
• P09.36 A new therapeutic strategy for newly diagnosed glioblastoma patients: hypofractionated stereotactic radiation therapy (HSRT) delivered in 15 fractions respect to standard fractionation in 30 fractions, with concomitant temozolomide chemotherapy - A phase II study
  由: Navarria, P., et al.
  出版: (2017)
• P08.10 Postoperative hypofractionated accelerated intensity modulated radiotherapy with concurrent and adjuvant temozolomide in the management of patients with newly diagnosed glioblastoma: results of a pilot study
  由: Biswas, A., et al.
  出版: (2016)
• P08.30 Extended temozolomide for newly diagnosed glioblastoma: an analysis of the German Glioma Network
  由: Gramatzki, D., et al.
  出版: (2016)